SATA

Society for the Advancement of Transplant Anesthesia

Newsletter

Summer 2022 Newsletter

By Leave a Comment

UNOS News

By Flora Simmons, MD

 

OPTN Board Eliminates Race-based Calculation For Transplant Listing

In a momentous measure to provide equitable access to all transplant candidates, the board of directors of the Organ Procurement and Transplantation Network recently approved a precedent requiring transplant hospitals to use race neutral calculations when estimating a candidate’s glomerular filtration rate (GFR).  Read more here.

 

Kidney Transplants have Increased in Minorities since Policy Changes 

Following implementation of the updated allocation system, one year monitoring reports show that transplant rates increased significantly for several key populations including Black, Hispanic, Asian, and pediatric candidates. The updated allocation system replaced the donation service area and administrative regions with a 250 nautical mile circle around the donor hospital. Read more here. 

 

Research Updates and Interesting Articles

By Michael Trostler, MD

 

“Abdominal Organ Transplantation: Noteworthy Literature in 2021”– Seminars in Cardiothoracic and Vascular Anesthesia

Highlights:  Yearly article by corresponding author, SATA president Dr. Tetsuro Sakai, selecting 20 articles from over 10,000 articles published over the year.  Read the article here

 

“Analysis of outcomes and renal recovery after adult living-donor liver transplantation among recipients with hepatorenal syndrome” – American Journal of Transplantation

Highlights:  Retrospective analysis of 2185 living donor liver transplants over a 7 year period found that time from HRS to transplant was significantly associated with recovery, and recovery was significantly associated with survival. Read the article here

 

“Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial” – American Journal of Transplantation

Highlights: Machine perfusion is at the forefront of new technological innovation in the transplant community.  A randomized control trial of HOPE in 110 extended criteria donors found improved outcomes with lower graft dysfunction and better graft survival. Read the article here

 

“Transplantation of a human liver following 3 days of ex situ normothermic preservation” – Nature Biotechnology

Highlights: 3 days of Ex-Vivo machine perfusion prior to transplant was successful and at one year follow-up the recipient was alive and the biliary tree intact.  Read the article for the amazing details here 

 

“Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump” – Liver International

Highlights: 12 European centers have followed 106 patients over 24 months with a “Alfapump”, an intraperitoneal fluid management system that pumps ascites from the peritoneal cavity into the bladder for excretion.  Designed for those ineligible for a TIPS procedure. Read the article here

 

“Sequential liver and kidney living donors: Making the ultimate gift twice” – Clinical Transplantation

Highlights: 150 living donors in the United States have donated more than one organ.  20 of these donors donated at UPMC- Pittsburgh, with 70% non-directed/altruistic with first donation and 80% non-directed/altruistic at the second donation. Read the article here

Special Topics

By Alex Stoker, MD

 

Imminent Death Donation

Imminent death donation (IDD) is a proposed organ donation practice described as the recovery of a living donor organ immediately prior to an impending and planned withdrawal of ventilator support expected to result in the patient’s death [OPTN white paper, 2016]. This practice is aimed at increasing the availability of donated organs through increased utilization of organs from donors who may have had non-progression during attempted DCD donation and by reducing organ ischemia.  In 2016 the ethics committee of the Organ Procurement & Transplantation Network (OPTN) outlined several ethical concerns, potential risks, as well as challenges of IDD; however, acknowledged the possibility of overcoming those challenges in the future [OPTN white paper, 2016]. A recent survey by Washburn et al explored the public attitudes towards IDD in the United States and describe a scenario in which one kidney, a portion of liver and portion of lung are donated prior to withdrawal of life support [Washburn et al, 2020]. 

Read more from reference here

 

Rise of the Machines – Normothermic Ex Vivo Perfusion in Liver Transplantation 

Since the first use of normothermic machine perfusion (NMP) in human orthotopic liver transplantation in 2013 there has been considerable and growing interest in using NMP to improve organ quality prior to transplantation by maintaining the allograft in a physiologic state during transportation. While ongoing investigations have yet to confirm all the potential benefits, NMP may reduce allograft ischemic damage, lessen the metabolic and hemodynamic derangements following liver reperfusion, increase the utilization of marginal organs, improve transplant logistics and expand the donor pool.

Read more from reference here

 

In the Spotlight: Duke University Medical Center –Cardiothoracic Transplant Program  

By David Rosenfeld, MD;  Alex Stoker, MD

For this summer’s piece we choose to focus exclusively on the adult cardiac and lung transplant program at Duke. A large medical center with 1048 patient care beds, Duke University Hospital is one of the premier centers in the world for cardiac and lung transplantation.  According to 2021 SRTR data they were third in the US in adult cardiac ​transplant volume with 104, second in lung with 108, and also performing three combined cardiac-lung ​transplants, and ​one lung-liver transplant. 

Led by ​Dr. Mihai Podgoreanu, the Duke Cardiothoracic Anesthesiology Division has been a leader in comprehensive perioperative management of thoracic organ and combined organ transplant recipients as members of the Duke Transplant Center, which recently celebrated its 10,000th transplant milestone. Perioperative transplant care is provided by a highly integrated group of cardiothoracic anesthesiologists and intensivists, 4 or 5 ​anesthesia residents, and up to 10 fellows covering a total of 9 adult cardiothoracic operating rooms and 32 CTICU beds.  Duke has one of the largest and busiest Adult Cardiothoracic Anesthesia (ACTA) fellowship programs in the US (14 fellows/year), led by Dr. ​Brandi Bottiger who also directs Quality Improvement across the Duke Transplant Center. Concomitantly, the Anesthesiology Critical Care Medicine (CCM) fellowship program​, led by Dr. Nazish Hashmi, is rapidly growing ​(8 fellows​/year), with a strong emphasis placed on acute care of critically ill transplant patients. Thoracic transplant recipients recover in the cardiothoracic intensive care unit (ICU), which offers 24/7 coverage by anesthesiologists with cardiothoracic and critical care training. The ACTA and CCM fellows participate in multidisciplinary care of these patients along the continuum from the operating room​ and through the cardiothoracic ICU, while gaining an unparalleled experience in perioperative echocardiography, complex cardiopulmonary and mechanical circulatory support physiology.

 

The Duke Heart Transplant program, under the medical directorship of Dr. Adam Devore, has a comprehensive patient selection process where many disciplines are represented, including anesthesiologists and intensivists.   Performing the first donation after circulatory death (DCD) case in 2019, the cardiac transplantation program has completed more than 80 heart transplant procedures with DCD donors.  To facilitate this innovative practice which significantly expands the donation pool, Duke has been early in its use of the Transmedics Organ Care System (OCS) and is one of five centers included in a prospective non-inferiority trial comparing transplantation of DCD organs resuscitated with the device compared to donation after brain death hearts preserved with traditional cold storage methods.  Dr. Jacob Schroder is the surgical director of heart transplantation and the principal investigator for the OCS DCD heart trial, which helped support the FDA’s approval of the device for DCD donor hearts in April 2022.  

Similarly, the Duke Lung Transplant program, under the medical directorship of Dr. John Reynolds, has a comprehensive, multidisciplinary patient selection process. Anesthesiologists are involved in developing quality metrics and improvements in clinical care. The Duke Lung Transplant​ program, with surgical director Dr. John Haney, has adopted elective intraoperative VA ECMO during lung transplantation to reduce allograft reperfusion injury, increase cardiopulmonary stability, and reduce comorbidity associated with cardiopulmonary bypass use. They utilize a hybrid ECMO circuit that can be quickly converted to a full CPB circuit if needed emergently. 

Transplantation is truly a team sport at Duke, with a dedicated multidisciplinary team in place to care for these complex patients.     

Many thanks to Dr. Bottiger for sharing details of  the transplantation program at Duke University Medical Center.  If interested in having your program highlighted in the future, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

Announcements

Attention liver transplant anesthesiologists and program directors!  SATA will be offering free 6 month membership to fellows!  Please sign up by emailing sata@pacainc.com. We look forward to welcoming new fellow members!

Transplant Anesthesia Upcoming Meetings

SATA Meetings:

Midstate SATA Regional Meeting: September 24, 2022

Southern SATA regional Meeting: November 5, 2022 

Mid-Western SATA Regional Meeting: January 21, 2023

 

Other Meetings: 

ILTS Perioperative Care in Liver Transplantation Meeting 2022

October 21, 2022; Ochsner Health, LA; in-person and virtual

The 2023 International Congress of ILTS, ELITA and LICAGE

May 3-6, 2023; Rotterdam, Netherlands

American Transplant Congress (ATC) 2023 Annual Meeting

June 3-7, 2023, San Diego, CA

Spring 2022 Newsletter

By Leave a Comment

UNOS News

By Flora Simmons, MD

Liver transplant rates increase after implementation of new organ allocation policy

The OPTN data report is now available and describes key measures of the new liver and intestinal allocation policy for the 18-month period from February 2020 through August 2021.  Results show an overall  increase in deceased donor liver-alone and liver-kidney transplants, significantly increased transplant rate for sicker patients, and more transplants being performed between 250 and 500 nautical miles, leading to slightly longer median cold ischemic times. Read more here.  

 

Record setting year for heart, liver, and kidney transplants in 2021

For the first time, organ transplants in the United States exceeded 40,000 for a grand total of 41,354 organs transplanted in 2021. There were a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants. Heart transplants have set a new record for the past 10 consecutive years, while liver transplants have set annual records for the past nine years.  Read more here. 

 

DCD Procurement Collaborative Project surpassed goal and recovered DCD donors at a higher rate than the rest of the nation

Twenty-six OPOs from across the country collaborated with the aim to increase the number of DCD donor procurements. Improvement efforts were focused across multiple areas including strengthening relationships between donor hospitals and transplant programs and optimizing clinical practices. The cohort procured 34% more DCD donors in 2021 compared to 26% for the rest of the nation. Read more here.

 

New relationship with Corey & Associates (PACA) 

From Susan Mandell, MD and David Corey, MBA

SATA is excited to announce a new partnership with Corey & Associates (PACA) that will assist with the day-to-day business management of the society’s activities.  PACA has worked in the area of management and government relations since 1975, SATA looks forward to working with PACA in order to improve this membership experience.  Please find a link to PACA on our webpage here 

 

SATA and SCA Collaboration Update  

By Yong G. Peng, MD, PhD, FASE, FASA

 With the help of SATA treasurer Dr. Jiapeng Huang preliminary communication, SATA executive council members Drs. Tetsuro Sakai, Jiapeng Huang and Susan Mandell had a Zoom meeting with the Society of Cardiovascular Anesthesiologists (SCA) leadership group.  This was a productive discussion covering a wide range of potential collaborations between SCA and SATA. 

SCA’s president Dr. Andrew Shaw has fully endorsed Drs. Archer Martin of Mayo Clinic Jacksonville and Sharon McCartney of Duke to become the inaugural Co-Chairs for the Transplant Anesthesia Subcommittee of SCA.  Together they will oversee all the projects and progress of collaboration between SATA and SCA.   

The initial area of mutual interest will include the following: 

  1. SATA and SCA will exchange a formal Memorandum of Understanding (MOU) to make the collaboration official 
  2. Both organizations recognize the mutual interests including but not limited to: a) data-based research (heart and lung). b) practice guidelines  c) advocacy to UNOS 
  3. Both societies leaders also agreed on the importance of structured training and educational process for adult lung transplantation (ALT) anesthesiologists. They will work on the specific logistics to provide TEE training curriculum and competency assessment for ALT anesthesiologists 

In response to the call for SATA and SCA collaborations, both SATA’s CT Transplantation Committee and CT Educational Task Force Committee recently had a Zoom meeting to lay out the specific action plans.  The committees proposed that SATA has three cardiothoracic related entities (CT transplantation Committee, TEE Work Group and CT Educational Taskforce) working together to consolidate resources and make a collective effort to reach important goals. These include promoting cardiothoracic related missions of SATA to other societies scientific activities, distribution of cardiothoracic transplantation educational materials on the SATA website, hosting regular meetings on relevant cardiothoracic transplant topics to maintain SATA member’s interest, and keeping all three entities member engagement to advance SATA’s clinical and research interest in collaboration with other professional societies.

 

Research Updates and Interesting Articles

By Michael Trostler, MD

  1. OPTN/SRTR 2020 Annual Data Report Liver,  has been published.  This is the first official update from the start of the pandemic.  As of June 2020, 98,989 liver transplant recipients were alive.  The report is full of interesting information on total numbers, demographics, and outcomes.  Read more here
  • Does machine perfusion improve immediate and short-term outcomes by enhancing graft function and recipient recovery after liver transplantation? – A systematic review of the literature, meta-analysis and expert panel recommendations

Highlights: Hypothermic machine perfusion decreases post-reperfusion syndrome and early graft dysfunction.  Normothermic machine perfusion reduces incidence of post-reperfusion syndrome and early graft dysfunction.  Normothermic regional perfusion decreases likelihood of early graft dysfunction and risk of primary non-function.  Read more here

  • Sequential hypothermic and normothermic machine perfusion enables safe

transplantation of high-risk donor livers

Highlights:  Sequential Dual hypothermic oxygenated machine perfusion followed by Normothermic Machine Perfusion (DHOPE-NMP) was used to salvage 63% of originally discarded livers with 1 year graft survival 94%, and patient survival 100%.  Read more here

  • Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.

Highlights:  Mortality after liver resection is nearly 50% higher than liver transplant in hepatocellular carcinoma.  Read more here

Articles of the month from January and February, 2022

By Michael Ander, MD

  • Postreperfusion syndrome in liver transplantation: outcomes, predictors, and application for recipient selection

Highlights:  Donor age, donor BMI, moderate macrosteatosis, and CIT were identified as risk factors for the development of PRS in LT using DBD grafts. PRS risk evaluation may improve donor-to-recipient matching based on their MELD scores. Read more here

  • Is obesity associated with better liver transplant outcomes? A retrospective study of hospital length of stay and mortality following liver transplantation

Highlights:  Results provide evidence that overweight and obesity class 1 are associated with decreased length of stay and mortality following liver transplant, while underweight and obesity class 3 are associated with prolonged length of stay.  Read more here

 

In the Spotlight:  Houston Methodist Medical Center (Texas Medical Center)

By David Rosenfeld, MD, FASA

For this quarter’s segment we were able to connect with Scott Lindberg, MD, FASA, director of liver transplant anesthesiology at the 900 bed Houston Methodist Medical Center. 

Currently Methodist is one of the busiest abdominal programs in the US with 183 livers, 255 kidneys (47% live donor), and 14 pancreas cases completed in 2021. For the liver program nearly all are cadaveric, however they have launched a liver donor program with their first case in October 2021, and a second scheduled in early 2022.  Methodist is aggressive in utilizing advanced age/extended criteria grafts with over 20% DCD.  They are frequently using the Transmedic normothermic perfusion system and are working to publish their early experience.  Nearly all cases are on VV bypass, PA catheter and FloTrac are routine, TEE is placed in nearly 100% of cases with one team member advanced certified.  ABG assays are POC in-room. ROTEM is performed in the central lab; however, the tracing is visible in real time in the OR. Antifibrinolytics are given with documented hyperfibrinolysis in conjunction with on field coagulopathy, and in cases when greater than eight units of packed cells are administered.  A small percentage of patients are extubated in the operating room.    

The most unique aspect of the liver transplant anesthesiology practice is that it is covered exclusively with a dedicated six-physician team from the private practice group US Anesthesia Partners working either as the sole in-room provider or in conjunction with UT Houston anesthesia residents, who rotate late in the CA2 and throughout the CA3 years.  Team members carry faculty appointments at the Weill Cornell School of Medicine and/or Texas A&M College of Medicine.  This private staffing model is clearly uncommon, and particularly unusual given that the program was the third largest volume US center in 2021.  Several years ago, Methodist hired liver transplant anesthesiologist Randolph Steadman, MD, MS, to serve as Chair of Anesthesiology, to lead the hospital-based group, and to increase collaboration between the private and hospital practices. In that vein, in September 2021 the department was accredited for an anesthesiology residency, with Dr. Lindberg of US Anesthesia Partners in the role of program director. It is an exciting time as they recently matched their first class of six categorical residents to begin in July 2022. 

The transplant program has made it their mission to expand the donor pool by looking to technology and data to push the boundaries of extended criteria donors.  There is also a commitment to increase research activity with the establishment of the residency program.

 

Upcoming Meetings

SATA Meetings 

SATA Tristate Liver Anesthesiology  Meeting, NYU School of Medicine, April 9th, 2022; 9:00 am – 2:00  pm EST. Click here to Register Click here to review the Program Agenda

SATA Virtual Lung Transplant Anesthesia Fellowship Series, April 16, 2022 6:00 PM EST.  Dr. Jack Hanley will be interviewed by Dr. Brandi Bottiger exploring a surgeon’s perspective on lung transplantation.  Click here for advanced registration. here 

SATA East Regional Meeting, DMV Liver Transplant Anesthesia Meeting 2022.  Virtual, April 23rd, 2022 8:45am – 12:45 pm EST.  Click here for details here 

Other Meetings

ILTS Annual Meeting May 4 – 7, 2022, Istanbul, Turkey

American Transplant Congress June 4 – 8, 2022, Boston, MA

International Liver Transplant Congress June 22 – 26, 2022

ILTS Perioperative Care in Liver Transplant Meeting, October 21, 2022, New Orleans, LA

 

Opportunities

UTHealth Anesthesiology – Medical Co-Director of the Transplant Intensive Care Unit

The Department of Anesthesiology at McGovern Medical School at UTHealth is seeking applicants for the position of Medical Co-Director of the Transplant Intensive Care Unit (TSICU) at Memorial Hermann Hospital- Texas Medical Center.  

The role of the Medical Co-Director is to oversee and integrate all clinical policies and practice standards in close cooperation and collaboration with the Chief of Transplant Surgery, Pulmonary Critical Care Medicine and other collaborating services in the Transplant Service Line. The Medical Co-Director will partner with the Chair of the Department and the Division Chief of Critical Care Medicine to promote a cohesive strategy to enhance patient care, structure educational systems, standardize translational research opportunities and infrastructure where appropriate and promote a culture of clinical excellence.  Additionally, the Medical Co-Director will contribute to the transplant anesthesiology team and collaborate with hospital leadership including the Transplant Service line administrative and nursing teams.

Required qualifications:

  1.     MD/DO or equivalent with Board Certification in Anesthesiology
  2.     Title or experience commensurate with a rank of Assistant Professor or greater
  3.     Fellowship training in an ACGME Accredited Critical Care Medicine program
  4.     Additional fellowship training in transplant anesthesiology is preferred

If interested, please submit your CV and cover letter to:

George Williams, MD, FASA, FCCM, FCCP

Vice Chair for Critical Care Medicine, Department of Anesthesiology

McGovern Medical School at UTHealth

George.W.Williams@uth.tmc.edu

Winter 2021 Newsletter

By Leave a Comment

In the Transplant News:

Flora Simmons, MD

UNOS Updates

  • ASTS Position Statement On The Role Of COVID-19 Vaccination For Transplant Candidates And Recipients: The American Society of Transplant Surgeons continues to recommend routine vaccination for all organ recipients (along with timely boosters). It also recommends vaccines for those on the waiting list, if possible. Read more at the ASTS Position Statement. 
  • Kidney Transplants Increase Across All Populations Following Policy Changes: Changes to kidney allocation were made in March of this year with the goal of improving access to organs and equality. Recent data shows that kidney transplants for all age groups, blood types, CPRA, and diagnoses have increased following the implementation of these new policies.  Read more at the UNOS News Section. 
  • Second Phase Of National DCD Procurement Collaborative Project Ready To Launch: UNOS has launched the second phase of a national collaborative improvement project to help organ procurement organizations (OPOs) identify and share effective practices related to recovery of donation after circulatory death (DCD) organs. Read more at the UNOS News Section.

In the Spotlight: The Miami Transplant Institute (MTI)

David Rosenfeld, MD

An affiliation between Jackson Health System and UHealth-the University of Miami Health System.

In this month’s feature we learn from Drs. Ramona Nicolau-Raducu and Yehuda Raveh some of the characteristics that are unique about MTI.  

The program is housed within the massive Jackson Memorial Hospital, one of the ten largest hospitals in the world with 2000 beds.   Year in and out they are amongst the busiest abdominal programs with a US leading 472 kidneys transplanted in 2020, including a paired exchange program.  MTI is also a front-runner in liver for the last 50 years, with over 4500 cases performed and 131 adult and 22 pediatric in 2020.  Pancreas transplant is equally robust.  For more than 20 years, and greater than 500 cases, a multidisciplinary team of experts at MTI has been treating thousands of children and adults with intestinal failure via Intestinal Rehabilitation or the Intestinal/Multivisceral Transplant Program, with outcomes well above national averages.  Along with deceased donor intestinal (~5 cases/year) and multivisceral transplants (~10-15 cases/year), autologous transplant procedures are offered.  

MTI became in recent years a bloodless center for Jehovah Witness transplants with a meticulous selection process for Jehovah’s Witness liver candidates.  A bloodless protocol has been established of using factor concentrates, hemopure (bovine hemoglobin-based oxygen carrying solution) autotransfusion and cell saver.

In February 2020 the national organ allocation system transformed from donor service area-based to an acuity circles-based model. Due to its unique geography near the tip of the Florida peninsula, the new system limits organ allocation.  As a result, use of DCD and other extended criteria grafts for liver or liver-kidney have increased, currently approximately 25% of liver grafts. In addition, patients listed for multivisceral transplantation are especially impacted by this change.  Due to specific quality requirements for suitable donors, which are typically younger and non-obese, the available donor pool is considerably smaller. Previously these patients were assigned amongst the highest status levels on the liver match run, but the current allocation model routinely prioritizes a suitable donor to a liver alone candidate that does not have the same size and quality limitations but has a high “competitive” MELD score.

The Abdominal Transplant Anesthesia Fellowship at Jackson Memorial Hospital was created in 2006 by Dr. Ernesto Pretto, Chief, Division of Transplant Anesthesia and is one of the largest in the nation with 4 fellows/year.  Transplant anesthesiology fellowships are non-ACGME accredited and are generally less popular for board eligible/certified US anesthesiology graduates, however this program has thrived through selecting highly qualified foreign graduates to consistently fill its positions.   They have graduated a remarkable 50 transplant fellows in the last 15 years (10% US graduates and 90% International).

Many thanks to Drs. Nicolau-Raducu and Yahuda for sharing details of their program. 

If interested in having your program highlighted, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

 Featured Publications in the Transplant Literature: 

Michael Trostler, MD

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size (Liang et al. BMC Surg. 2021) 

Since 1996 Milan criteria for hepatocellular carcinoma has been used to guide liver transplantation to those who would benefit most and restrict deceased donor organs to those with the highest likelihood of survival. Living donor transplants tend to be directed to individuals who do not meet this criteria if the donor and recipient understand the potential risk. Liang et al. out of Taiwan report on 155 patients, 78 of which were beyond Milan criteria for tumor size or number found similar outcomes and recurrence rates. They propose a new criteria: maximum tumor size <= 6cm and total tumor size < 10cm.

Challenges and opportunities for treating intrahepatic cholangiocarcinoma (Serifis et al. Hepat Med. 2021)

There is potential to expand transplant criteria for living donor liver transplantation with less stringent criteria for directed donors. In addition to the potential for an expanded hepatocellular carcinoma guideline, cholangiocarcinoma is another disease process with historically poor outcomes which may be treated by transplantation with strict selection criteria, operative staging, and neoadjuvant therapy. 

Liver transplant outcomes after ex vivo machine perfusion: A meta-analysis (Liew et al. Br J Surg. 2021)

Ex-vivo machine perfusion – Meta-analysis included 34 articles with odds ratios favoring hypothermic machine perfusion over static cold storage. Findings include: decreased early graft dysfunction, ischemic cholangiopathy, non-anastamotic strictures and graft loss. Machine perfusion was associated with shorter length of stay. Normothermic perfusion is associated with reduced graft injury. 

Machine perfusion organ preservation: Highlights from the American Transplant Congress 2021 (Pavan-Guimaraes et al. Artif Organs. 2021)

At the American Transplant Congress (June 2021) 33 abstracts on machine perfusion were presented including heart, lung, liver and kidney. Machine perfusion may become gold standard in the future as innovation and advancement bring down costs and improve outcomes. 

SATA Committee’s Update

Yong G Peng, MD, PhD

We caught up with the Quality and Standards Committee Chair, Dr. Adrian Hendrickse (Associate Professor, University of Colorado). The members of the committee have been working hard on several surveys. The first survey, led by Dr. Cara Crouch (Assistant Professor, University of Colorado), looked at Adult Liver Transplant Anesthesiology practice patterns across the US. Their research was published in the Journal of Clinical Transplantation. (Crouch et al. Clin Transplant. 2021)

Additionally, a smaller sub-committee of members are interested in living donor liver transplantation (LDLT) status. The group, headed by Dr. Tetsuro Sakai (SATA president), has investigated LDLT programs across the US. They have submitted their findings in an abstract to the 2022 IARS/AUA and ILTS meetings. They plan to prepare a manuscript of their findings. The committee has worked closely with the Korean Society of Anesthesiologists in an effort to write a collaborative review of LDLT practice, which they are planning to submit to Clinical Transplantation. 

The Q&S committee members have worked on several other research projects, including similar survey-based methods, investigating different organ transplantation services, and pursuing the development of SATA endorsed guidelines for our subspecialty.

News clips from the Executive Board of SATA

Lorenzo De Marchi, MD, Secretary, SATA

The SATA council wishes its members a happy holiday and new year.  We are always looking for ways to ensure SATA meets your needs.  Send us your suggestions.  We are listening.  Let us update you on the most recent and exciting projects in the works.  

Membership renewal:  We look forward to working with you in the upcoming year so don’t forget to renew for 2022.  There is easy access on the website. New members will receive six months free SATA membership.  Let your colleagues know. 

The SATA-Data Collection Project; a collaborative data collection project that extends the American College of Surgeons NSQIP to  anesthesia outcome measures of abdominal transplantation.  Headed by Dieter Adelman an anesthesiologist from UCSF and Stuart Greenstein, a surgeon from Montefiore.  If your center wants to participate, please reach out to Dr. Dieter Adelman (dieter.adelmann@ucsf.edu) and Dr. Sher-Lu Pai (pai.sherlu@mayo.edu) for information.

New Professional Associations: SATA and the Society for Cardiovascular Anesthesia have agreed to work together on shared interests in both heart and lung transplantation.  We thank SATA President Dr. Ted Sakai and SATA Treasurer Dr. Jiapeng Huang, in addition to  Dr. Archer Martin from SCA for their hard work on this project.

New Committee:  SATA approves new Critical Care Medicine Committee.  Please contact Dr. Ranjiit Deshpande through the SATA home link to apply and find out more.

Expanding SATA research:  Go to the web to apply for the Society’s endorsement for your research project. Submit your application to the SATA Secretary (demarchilorenzo@yahoo.com) for Council review and feedback.

Mark the calendar and pack your flipflop and sunscreen!!

The SATA annual meeting at the IARS is in Hawaii on Monday, March 21th, 2022 as an in-person meeting.  If you can’t be there don’t forget about upcoming SATA regional meetings with CME credits.  Check on the Society’s website for a complete list and dates.

Explore Educational Content

Webinars

August 2021: Rise of the Machines in Solid Organ Transplant

February 2021: Pro/Con Debate: Routine Anticoagulation in Liver Transplantation 

October 2020: Pro/Con Debate: ECMO vs Cardiopulmonary Bypass in Lung Transplantation 

June 2020: Transplant Anesthesiology during the COVID-19 Pandemic 

Vanguard Expert Lecture Series

June 2021: Evaluation for Lung Transplantation: Pulmonologist Perspective 

March 2021: Living Donor Liver Transplantation: Donor Management 

 

Fellowship Lecture Series

August 2021: Cardiovascular Assessment of Liver Transplantation Candidates 

June 2021: Multivisceral Transplantation 

May 2021: Acute Liver Failure 

 

Transplant Anesthesia Upcoming Meetings

SATA Meetings 

SATA West Coast Liver Transplant Anesthesia Meeting, December 11, 2021 9am – 12:30pm PST – Register for the Virtual Meeting

SATA Midwest Meeting, January 22nd, 2022; 8:55 am – 12:30 PM CST – Register for the Virtual Meeting

SATA National Meeting at IARS, March 21, 2022, Honolulu, HI

SATA Tristate Meeting, April 9th, 2022

Other Transplant Anesthesia Meetings

ILTS Virtual Consensus Conference January 28-29, 2022

IARS Annual Meeting March 18 – 21, 2022, Honolulu, HI

ILTS Annual Meeting May 4 – 7, 2022, Istanbul, Turkey
 
Are you enjoying the SATA Newsletter? Please fill out a quick survey!

 
BOARD OF DIRECTORS: TERM  2021 – 2022

President
Tetsuro Sakai, MD, PhD, MHA, FASA

Immediate Past President
M. Susan Mandell, MD, PhD

Founding President
Ernesto A. Pretto Jr., MD, MPH 

President-elect
Gebhard Wagener, MD

Secretary
Lorenzo De Marchi, MD

Treasurer
Jiapeng Huang, MD, PhD, FASA, FASE

Executive Council
Ranjit Deshpande MBBS
Adrian Hendrickse, BM, PgDipMEd, MAcadMEd, FRCA
Christine Nguyen-Buckley, MD
Ramona Nicolau-Raducu, MD, PhD

Newsletter Editor-in-Chief

Yong G Peng MD, PhD

 

Newsletter Editorial Board

Sennaraj Balasubramanian, MD
Amit Bardia, MD
Jiapeng Huang, MD, PhD, FASA, FASE
M. Susan Mandell, MD, PhD
Sergio Navarrete, DO
David Rosenfeld, MD
Flora Simmons, MD
Natalie Smith, MD
Michael Trostler MS, MD

Fall 2021 Newsletter

By Leave a Comment

New SATA Leadership Announced on August 1, 2021

Tetsuro Sakai, MD, PhD, MHA is the new President. The new SATA leaderships include Gebhard Wagener, MD (President-Elect: Columbia University), Lorenzo De Marchi, MD (Secretary: Georgetown University), and Jiapeng Huang, MD, PhD (Treasurer: University of Louisville), as well as Executive Councilors Ranjit Deshpande, MD (Yale University), Adrian Hendrickse, BM, FRCA (University of Colorado), Christine Nguyen-Buckley, MD (UCLA), and Ramona Nicolau-Raducu, MD, PhD (University of Miami). Dr. M. Susan Mandell serves as the Immediate Past President. Dr. Ernest Pretto, Jr. is the Founding President. 

 To see more join SATA.

Table of Contents

  1. New SATA Leadership Announced on August 1, 2021
  2. President’s Message: SATA – Ever Innovative, Inclusive, and Fiercely Active!
  3. Webinar: Rise of the Machines in Solid Organ Transplantation
  4. In the Transplant News:
  5. In the Spotlight: University of Virginia Medical Center
  6. Featured Publications in the Transplant Literature:
  7. SATA Committee’s Update
  8. Council Meeting Update
  9. Transplant Anesthesia Upcoming Meetings

This content is for SATA Members only

Login To have access to the Content!

Summer 2021 Newsletter

By

Important Society Election News for All SATA Members

Flora Simmons and Susan Mandell

The SATA News teams would like to remind all SATA members of the upcoming elections for the executive council.  Each member can cast a vote for two Councilor at Large and the Treasurer of the Society.   Look for more announcements on this important upcoming election and cast your vote.  Biographical snapshots of each candidate will be circulated to all SATA members to help you decide which candidate you want to help pave our path for the future. 

Pro/Con Debate: Anticoagulation During Liver Transplantation Webinar

Sathish Kumar and Yong Peng

On February 23rd SATA hosted a pro-con debate webinar on anticoagulation during liver transplantation as part of its ongoing interactive educational initiative. The debate focused on the difficult issue of anticoagulation during transplant surgery for prophylaxis and treatment of clots that arise during the transplant procedure. To see more join SATA.

Table of Contents

  • Important Society Election News for All SATA Members
  • Pro/Con Debate: Anticoagulation During Liver Transplantation Webinar  
  •  SATA New England Symposium Summary
  • In the Spotlight: University of Nebraska Medical Center
  • Featured Publications: Heart, Lung, and Abdominal Organ Transplant
  • Transplant Anesthesia Upcoming Meetings
  • SATA representation at SCA
  • The 17th Virtual Conference of the Egyptian Cardiothoracic Anesthesia Society

Full Feature News Letter

This content is for SATA Members only

Login To have access to the Content!


Are you enjoying the SATA Newsletter? Please fill out a quick survey!
 

BOARD OF DIRECTORS: TERM  2020 – 2021

President

M. Susan Mandell, MD, PhD

Immediate Past President
Ernesto A. Pretto, Jr. MD, MPH

President-elect

Tetsuro Sakai, MD, PhD, MHA, FASA

Secretary

Gebhard Wagener, MD

Treasurer

Lorenzo De Marchi, MD

Executive Council
Jiapeng Huang, MD, PhD, FASA, FASE
Kathirvel Subramaniam, MD, MPH, FASE
Adrian Hendrickse, BM, PgDipMEd, MAcadMEd, FRCA
Ranjit Deshpande MBBS

Newsletter Editor-in-Chief
Yong G Peng MD, PhD

Newsletter Editorial Board

Susan Mandell, MD, PhD
Jiapeng Huang, MD, PhD, FASA, FASE
Amit Bardia, MD
Sergio Navarrete, DO
David Rosenfeld, MD
Flora Simmons, MD
Natalie Smith, MD

Spring 2021 Newsletter

By

Spring 2021 Newsletter

Featured Publications

  • From the Journal of Clinical Transplantation
    • The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience. (Guorgui et al. 2021)

Multicenter Liver Transplantation Collaboration

  • SATA is pleased to announce the successful launch of a multicenter study to improve the quality of liver transplant anesthesia care – the SATA Liver Transplant Anesthesia Database Project. 

More in the SATA member section…

Table of Contents

  • Featured Publications
  • Multicenter Liver Transplantation Collaboration
  • Upcoming Meetings
  • Liver Failure Management
  • Upcoming SATA Webinar
  • CT Transplantation Committee Update
  • SATA Virtual Meeting Summary
  • SATA at the Chinese American Society of Anesthesiology
  • Calling all transplant programs! Tell us your story
  • Pediatric Liver Transplant Survey

Full Feature News Letter

This content is for SATA Members only

Login To have access to the Content!

BOARD OF DIRECTORS: TERM  2020 – 2021

President

M. Susan Mandell, MD, PhD

Immediate Past President
Ernesto A. Pretto, Jr. MD, MPH

President-elect

Tetsuro Sakai, MD, PhD, MHA, FASA

Secretary

Gebhard Wagener, MD

Treasurer

Lorenzo De Marchi, MD

Executive Council
Jiapeng Huang, MD, PhD, FASA, FASE
Kathirvel Subramaniam, MD, MPH, FASE
Adrian Hendrickse, BM, PgDipMEd, MAcadMEd, FRCA
Ranjit Deshpande MBBS

Newsletter Editor-in-Chief
Yong G Peng MD, PhD

Newsletter Editorial Board

Susan Mandell, MD, PhD
Jiapeng Huang, MD, PhD, FASA, FASE
Amit Bardia, MD
Sergio Navarrete, DO
David Rosenfeld, MD
Flora Simmons, MD
Natalie Smith, MD

Summer 2020 Newsletter

By

Summer 2020 Newsletter

Letter from the President

Dear SATA members,
It has been a time of great reflection in the nation.  The death of Mr. George Floyd ignited an outcry for immediate change.   Our role as physicians and caregivers to the public has never been more important than now.  We share the public’s grief at the injustice and civil unrest, but know we must remain strong because we are and will always be the ones people rely on in the most difficult times.  
In these challenging times I believe there is no greater time of hope than now.  We contribute by continuing our time-honored tradition of doing the most to honor and save every life; one at a time.  This is our commitment to all humanity.  As transplant anesthesiologists, we have a unique understanding of the purposeful work it takes to ensure every person has an equal access to all resources.  We believe that every single life matters. 
I send this message to all our members to thank you for the tireless work you continue to do that serves the public. 

Welcome to our new Councilors-at-Large:

Welcome to Dr. Adrian Hendrickse from the University of Colorado and Dr. Ranjit Deshpande from Yale University who will serve on the executive council for a two-year term. We thank Dr. Jeron Zerillo from Mount Sinai Icahn School of Medicine in NY and Dr. Ryan Chadha from the Mayo Clinic in Jacksonville FL for their service as Councilors at-Large. We recognize our membership for selecting our new representatives. 
Introducing the SATA Webinar Series

SATA is introducing a webinar series for our membership.  The first in this series is “Transplant Anesthesiology During the COVID-19 Pandemic”: a Zoom event on June 25, 2020 at 5:00 EST.  Join transplant anesthesiologists from the country’s COVID-19 hot spots to hear what they learned. Sign up and access the Webinar through the SATA website.  

In the Transplant News

Visit UNOS.org for the latest updates and webinars on the COVID-19 pandemic and its effects on transplantation

UNOS reaffirms their commitment to saving and improving lives through transplantation, regardless of background, including race and ethnicity.  Irene Kim MD and Paulo Martins MD, PhD explain that equity is the fundamental goal of the transplant community and how this goal is incorporated into the Final Rule which mandates the OPTN ensures “the equitable allocation of cadaveric organs.” Read more here
 
The existing system for kidney and pancreas organ allocation is revised.  These changes include a new definition of medical urgency for kidney transplant candidates and allocation priority for those meeting the criteria, procedures for reallocating organs accepted for a candidate but not transplanted, and allocation of organs from Alaska where there is no transplant program.  

Commentary on the dangers of standardized practices in heart transplant.  Read more at here